BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1025377 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 12.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025378 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H28Cl2FNO4/c1-27(2,36)20-13-23-25(24(32)14-20)29(19-5-9-22(31)10-6-19,37-17-28(16-34)11-12-28)33(26(23)35)15-18-3-7-21(30)8-4-18/h3-10,13-14,34,36H,11-12,15-17H2,1-2H3/t29-/m1/s1 QUBUREFIXVDKEB-GDLZYMKVSA-N 427047 US10544132, Example 2::US10981898, Example 2::US11236047, Example 2 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 4.60 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427047&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281669 434321364 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025379 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCO)c1ccc(Cl)cc1 InChI=1S/C26H25Cl2NO4/c1-25(2,32)19-7-12-23-22(15-19)24(31)29(16-17-3-8-20(27)9-4-17)26(23,33-14-13-30)18-5-10-21(28)11-6-18/h3-12,15,30,32H,13-14,16H2,1-2H3/t26-/m1/s1 BDOTXISZENQYGP-AREMUKBSSA-N 427048 US10544132, Example 3::US10981898, Example 3::US11236047, Example 3 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 93.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427048&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281430 434321365 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025380 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(2,35)21-7-12-25-24(13-21)26(34)32(14-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)37-18-28(15-33)16-36-17-28/h3-13,33,35H,14-18H2,1-2H3/t29-/m1/s1 GDUHFOYTYPKEOT-GDLZYMKVSA-N 427049 US10544132, Example 4::US10981898, Example 4::US11236047, Example 4 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 43.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427049&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281482 434321366 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025381 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C(O)=O)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2NO5/c1-27(2,36)20-7-12-24-23(15-20)25(33)32(16-18-3-8-21(30)9-4-18)29(24,19-5-10-22(31)11-6-19)37-17-28(13-14-28)26(34)35/h3-12,15,36H,13-14,16-17H2,1-2H3,(H,34,35)/t29-/m1/s1 IAJLMKLNFWIPMA-GDLZYMKVSA-N 427050 US10544132, Example 5::US10981898, Example 5::US11236047, Example 5 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 140 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427050&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281515 434321367 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025382 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC(C)(O)CO)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO5/c1-18(19-5-10-22(30)11-6-19)32-26(34)24-15-21(27(2,3)35)9-14-25(24)29(32,37-17-28(4,36)16-33)20-7-12-23(31)13-8-20/h5-15,18,33,35-36H,16-17H2,1-4H3/t18-,28?,29+/m0/s1 UUZINBSIYDKSFT-PDIMESBLSA-N 427051 US10544132, Example 6::US10981898, Example 6::US11236047, Example 6 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 120 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427051&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281509 434321368 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025383 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-19(20-4-9-23(31)10-5-20)33-27(35)25-16-22(28(2,3)36)8-13-26(25)30(33,21-6-11-24(32)12-7-21)37-18-29(17-34)14-15-29/h4-13,16,19,34,36H,14-15,17-18H2,1-3H3/t19-,30+/m0/s1 OBIKGGOHRXESCS-WWOZWPLTSA-N 427053 US10544132, Example 7::US10981898, Example 7::US11236047, Example 7 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 6.60 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427053&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281662 434321370 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025384 C[C@](O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27-,29+/m0/s1 NVLQHQFGNPTQCC-LMSSTIIKSA-N 427054 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(1,2-dihydroxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 8::US10981898, Example 8 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 4.70 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427054&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732949 434321371 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025385 C[C@@](O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27-,29-/m1/s1 NVLQHQFGNPTQCC-XRKRLSELSA-N 427055 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(1,2-dihydroxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 9::US10981898, Example 9 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 11.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427055&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732950 434321372 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025386 COC[C@](C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29-,31+/m0/s1 UIFBZUZURMPJLE-CRIGUBNMSA-N 427056 (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-6-(2-hydroxy-1-methoxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 10::US10981898, Example 10 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 3.70 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427056&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732951 434321373 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025387 COC[C@@](C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29+,31+/m0/s1 UIFBZUZURMPJLE-XCIXRLFOSA-N 427057 (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-6-(2-hydroxy-1-methoxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 11::US10981898, Example 11 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 33.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427057&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732952 434321374 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025388 CN(C)C[C@@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29-,31-/m1/s1 FLSKRFKVCWLISS-BVRKHOPBSA-N 427060 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[1-(dimethylamino)-2-hydroxypropan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 13::US10981898, Example 12 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 5.80 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427060&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732954 434321377 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025389 CN(C)C[C@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29-,31+/m0/s1 FLSKRFKVCWLISS-IGYGKHONSA-N 427058 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[1-(dimethylamino)-2-hydroxypropan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 12::US10981898, Example 13 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 120 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427058&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732953 434321375 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025390 CC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](CC(O)=O)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H31Cl2NO6/c1-29(2,39)21-7-12-25-24(15-21)28(38)34(26(16-27(36)37)19-3-8-22(32)9-4-19)31(25,20-5-10-23(33)11-6-20)40-18-30(17-35)13-14-30/h3-12,15,26,35,39H,13-14,16-18H2,1-2H3,(H,36,37)/t26-,31+/m0/s1 ZJSPHSZNTWLUQB-SUYBVONHSA-N 427061 US10544132, Example 14::US10981898, Example 14::US11236047, Example 14 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 5.00 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427061&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 137405302 434321378 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025391 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(O)CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO5/c1-19(20-3-8-23(31)9-4-20)33-27(36)25-15-22(28(2,37)16-34)7-12-26(25)30(33,21-5-10-24(32)11-6-21)38-18-29(17-35)13-14-29/h3-12,15,19,34-35,37H,13-14,16-18H2,1-2H3/t19-,28?,30+/m0/s1 HLYNUXSLMMUNHC-WDWHWGHSSA-N 427062 US10544132, Example 15::US10981898, Example 15::US11236047, Example 15 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 19.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427062&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281406 434321379 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025392 CC(C)(O)CCO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO4/c1-27(2,34)15-16-36-29(20-7-12-23(31)13-8-20)25-14-9-21(28(3,4)35)17-24(25)26(33)32(29)18-19-5-10-22(30)11-6-19/h5-14,17,34-35H,15-16,18H2,1-4H3/t29-/m1/s1 QFAIKCYCAGIEDP-GDLZYMKVSA-N 427063 US10544132, Example 16::US10981898, Example 16::US11236047, Example 16 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 140 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427063&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281465 434321380 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025393 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCc1cn[nH]c1)c1ccc(Cl)cc1 492921 US10981898, Example 17::US11236047, Example 17 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 63.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492921&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281433 447119610 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025394 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C#N)c1ccc(Cl)cc1 InChI=1S/C29H26Cl2N2O3/c1-27(2,35)21-7-12-25-24(15-21)26(34)33(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-32)13-14-28/h3-12,15,35H,13-14,16,18H2,1-2H3/t29-/m1/s1 CHHGWWCMCGHFMJ-GDLZYMKVSA-N 427065 US10544132, Example 18::US10981898, Example 18::US11236047, Example 18 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 45.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427065&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281503 434321382 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025395 CCC1(COC2(N(Cc3ccc(Cl)cc3)C(=O)c3cc(ccc23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H31Cl2NO3/c1-4-29(15-16-29)19-36-30(21-7-12-24(32)13-8-21)26-14-9-22(28(2,3)35)17-25(26)27(34)33(30)18-20-5-10-23(31)11-6-20/h5-14,17,35H,4,15-16,18-19H2,1-3H3 ONXUOCISKNKLEO-UHFFFAOYSA-N 492926 US10981898, Example 19 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 22.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492926&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 156907814 447119615 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025396 CC(C)[Si](C#Cc1ccc(CN2C(=O)c3cc(ccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)C(C)(C)O)cc1)(C(C)C)C(C)C InChI=1S/C40H50ClNO4Si/c1-27(2)47(28(3)4,29(5)6)22-19-30-9-11-31(12-10-30)24-42-37(44)35-23-33(38(7,8)45)15-18-36(35)40(42,32-13-16-34(41)17-14-32)46-26-39(25-43)20-21-39/h9-18,23,27-29,43,45H,20-21,24-26H2,1-8H3 MSTKICFKUWVYLG-UHFFFAOYSA-N 492927 US10981898, Example 20 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 11.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492927&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 145765537 447119616 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025397 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#C)C(OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO4/c1-4-20-5-7-21(8-6-20)17-34-28(36)25-15-23(29(2,3)37)16-26(33)27(25)31(34,22-9-11-24(32)12-10-22)38-19-30(18-35)13-14-30/h1,5-12,15-16,35,37H,13-14,17-19H2,2-3H3 NBPAQCMFLGCFBK-UHFFFAOYSA-N 492928 US10981898, Example 21 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 7.80 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492928&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 156907815 447119617 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025398 C[C@@](O)(CO)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO5/c1-3-20-4-6-21(7-5-20)16-34-28(37)25-14-23(29(2,38)17-35)15-26(33)27(25)31(34,22-8-10-24(32)11-9-22)39-19-30(18-36)12-13-30/h1,4-11,14-15,35-36,38H,12-13,16-19H2,2H3/t29-,31-/m1/s1 LDOCNQIRVXHZQU-BVRKHOPBSA-N 492929 US10981898, Example 22 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 5.20 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492929&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 156907816 447119618 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025399 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#N)C(OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28ClFN2O4/c1-28(2,37)22-13-24-26(25(32)14-22)30(21-7-9-23(31)10-8-21,38-18-29(17-35)11-12-29)34(27(24)36)16-20-5-3-19(15-33)4-6-20/h3-10,13-14,35,37H,11-12,16-18H2,1-2H3 DIVMTXBUDOMYFO-UHFFFAOYSA-N 492930 US10981898, Example 24 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 7.50 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492930&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 156907817 447119619 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025400 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O4/c1-28(2,36)23-9-12-26-25(15-23)27(35)33(17-21-5-3-20(16-32)4-6-21)30(26,22-7-10-24(31)11-8-22)37-19-29(18-34)13-14-29/h3-12,15,34,36H,13-14,17-19H2,1-2H3/t30-/m1/s1 KUYDFZZMIJDWQY-SSEXGKCCSA-N 427071 US10544132, Example 25::US10981898, Example 25::US11236047, Example 25 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 7.20 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427071&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281419 434321387 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025401 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(C)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,34)21-8-13-25-24(14-21)26(33)32(15-19-4-9-22(30)10-5-19)29(25,20-6-11-23(31)12-7-20)36-18-28(3)16-35-17-28/h4-14,34H,15-18H2,1-3H3/t29-/m1/s1 JPJMGSQFTCZFQV-GDLZYMKVSA-N 427072 US10544132, Example 26::US10981898, Example 26::US11236047, Example 26 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 32.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427072&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281408 434321388 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025402 CC(=C)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)C2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H27ClN2O3/c1-20(2)23-7-12-27-26(15-23)28(35)33(17-22-5-3-21(16-32)4-6-22)30(27,24-8-10-25(31)11-9-24)36-19-29(18-34)13-14-29/h3-12,15,34H,1,13-14,17-19H2,2H3 WHLZDVKKTGHCMQ-UHFFFAOYSA-N 492933 4-((1-(4-Chlorophenyl)-1-((1-(hydroxymethyl)cyclopropyl)methoxy)-3-oxo-5-(prop-1-en-2-yl)isoindolin-2-yl)methyl)benzonitrile::US10981898, Example 27 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 65.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492933&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281479 447119622 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025403 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O5/c1-28(37,17-34)23-8-11-26-25(14-23)27(36)33(16-21-4-2-20(15-32)3-5-21)30(26,22-6-9-24(31)10-7-22)38-19-29(18-35)12-13-29/h2-11,14,34-35,37H,12-13,16-19H2,1H3/t28?,30-/m1/s1 WAODAYOZKYTGDR-FUJFQHJFSA-N 492934 US10981898, Example 28::US11236047, Example 28 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 26.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492934&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281411 447119623 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025404 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)C2(OCC1(CC1)O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)c1ccc(Cl)cc1 InChI=1S/C44H45Cl2NO4Si/c1-41(2,3)52(36-12-8-6-9-13-36,37-14-10-7-11-15-37)51-43(26-27-43)30-50-44(32-18-23-35(46)24-19-32)39-25-20-33(42(4,5)49)28-38(39)40(48)47(44)29-31-16-21-34(45)22-17-31/h6-25,28,49H,26-27,29-30H2,1-5H3 NRSLMJAUYKGDGV-UHFFFAOYSA-N 492935 US10981898, Example 29 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 110 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492935&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 145765568 447119624 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025405 CN(C)C(=O)COC1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(Br)ccc12)c1ccc(Cl)cc1 InChI=1S/C25H21BrCl2N2O3/c1-29(2)23(31)15-33-25(17-5-10-20(28)11-6-17)22-12-7-18(26)13-21(22)24(32)30(25)14-16-3-8-19(27)9-4-16/h3-13H,14-15H2,1-2H3 DXEVITVMQBDYAY-UHFFFAOYSA-N 492936 US10981898, Example 30 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 86.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492936&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281633 447119625 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025406 COCC1(CO[C@]2(N(Cc3ccc(Cl)cc3)C(=O)c3cc(ccc23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H31Cl2NO4/c1-28(2,35)22-8-13-26-25(16-22)27(34)33(17-20-4-9-23(31)10-5-20)30(26,21-6-11-24(32)12-7-21)37-19-29(14-15-29)18-36-3/h4-13,16,35H,14-15,17-19H2,1-3H3/t30-/m1/s1 RARQEPSEJKMFPX-SSEXGKCCSA-N 427077 US10544132, Example 31::US10981898, Example 31::US11236047, Example 31 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 38.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427077&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281414 434321393 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025407 CC(=O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1Br)C2(O)c1ccc(Cl)cc1 InChI=1S/C23H16BrCl2NO3/c1-13(28)14-3-9-20-19(10-14)22(29)27(12-15-2-6-18(26)11-21(15)24)23(20,30)16-4-7-17(25)8-5-16/h2-11,30H,12H2,1H3 BVRNRDKNHVCXOA-UHFFFAOYSA-N 492938 US10981898, Example 33 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.90 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492938&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281516 447119627 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025408 CC(=O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(=O)(=O)N1CCOCC1)C2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2N2O7S/c1-21(38)22-3-9-28-27(16-22)30(39)36(32(28,24-4-7-25(33)8-5-24)43-20-31(19-37)10-11-31)18-23-2-6-26(34)17-29(23)44(40,41)35-12-14-42-15-13-35/h2-9,16-17,37H,10-15,18-20H2,1H3 DGEPPPXNDGHECM-UHFFFAOYSA-N 492939 US10981898, Example 34 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 4.60 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492939&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 137411599 447119628 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025409 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2FN2O6S/c1-28(2,38)19-12-22-25(23(33)13-19)30(18-5-8-20(31)9-6-18,41-16-29(10-11-29)27(34)37)35(26(22)36)15-17-4-7-21(32)14-24(17)42(3,39)40/h4-9,12-14,38H,10-11,15-16H2,1-3H3,(H2,34,37)/t30-/m1/s1 QXTIAAQSOXPAAN-SSEXGKCCSA-N 492940 US10981898, Example 35::US11236047, Example 35 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.80 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492940&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281548 447119629 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025410 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(C)(=O)=O)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO6S/c1-28(2,36)21-7-11-25-24(14-21)27(35)33(16-19-4-8-23(32)15-26(19)40(3,37)38)30(25,20-5-9-22(31)10-6-20)39-18-29(17-34)12-13-29/h4-11,14-15,34,36H,12-13,16-18H2,1-3H3/t30-/m1/s1 RXUWUIRMPWZSAR-SSEXGKCCSA-N 427081 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-3-({1-[hydroxy(2H2)methyl]cyclopropyl}(2H2)methoxy)-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 36::US10981898, Example 36::US11236047, Example 36 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.90 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427081&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732958 434321397 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025411 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(O[C@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23-,28+/m0/s1 ITVICYXWRBVNRA-NEKDWFFYSA-N 427083 (3R)-3-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-(oxolan-3-yloxy)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 38::US10981898, Example 37 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 41.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427083&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732960 434321399 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025412 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(O[C@@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23-,28-/m1/s1 ITVICYXWRBVNRA-QDPGVEIFSA-N 427082 (3R)-3-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-(oxolan-3-yloxy)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 37::US10981898, Example 38 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 26.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427082&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732959 434321398 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025413 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20-,29-/m1/s1 OTIYWWDOPCSJHZ-ACSYHNTCSA-N 427085 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-[(oxolan-3-yl)methoxy]-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 40::US10981898, Example 39 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 68.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427085&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732962 434321401 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025414 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20-,29+/m0/s1 OTIYWWDOPCSJHZ-AFJIDDCJSA-N 427084 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-[(oxolan-3-yl)methoxy]-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 39::US10981898, Example 40 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 63.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427084&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732961 434321400 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025415 C[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO7S/c1-32(41,22-9-13-44-14-10-22)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,45-20-33(19-39)11-12-33)38(31(27)40)18-21-3-6-26(36)17-29(21)46(2,42)43/h3-8,15-17,22,39,41H,9-14,18-20H2,1-2H3/t32-,34-/m1/s1 JFGISRYCIHBUCK-ZFEZZJPFSA-N 427086 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[1-hydroxy-1-(oxan-4-yl)ethyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 41::US10981898, Example 41 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.60 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427086&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732963 434321402 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025416 C[C@](O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H38Cl2FN3O6S/c1-32(43,19-39-13-11-38-12-14-39)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,46-21-33(20-41)9-10-33)40(31(27)42)18-22-3-6-26(36)17-29(22)47(2,44)45/h3-8,15-17,38,41,43H,9-14,18-21H2,1-2H3/t32-,34+/m0/s1 NTYHQRPYZXGTGT-UZNNEEJFSA-N 427089 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(piperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 44::US10981898, Example 44 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 5.80 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427089&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732966 434321405 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025417 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OC1COC[C@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25+,26?,29+/m0/s1 JLJRDOGQKDSPHW-BKVJDPFESA-N 427090 (3R)-3-(4-Chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3S,4R)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one and (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3R,4S)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 45::US10981898, Example 45::US11236047, Example 45 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 230 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427090&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 145765588 434321406 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025418 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OC1COC[C@@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25-,26?,29+/m0/s1 JLJRDOGQKDSPHW-QYEDSFCJSA-N 427091 (3R)-3-(4-Chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3S,4R)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one and (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3R,4S)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 46::US10981898, Example 46 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 10780 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427091&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732967 434321407 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025419 CO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C25H23Cl2NO3/c1-24(2,30)18-8-13-22-21(14-18)23(29)28(15-16-4-9-19(26)10-5-16)25(22,31-3)17-6-11-20(27)12-7-17/h4-14,30H,15H2,1-3H3/t25-/m1/s1 GBBKEWOTKMXEJW-RUZDIDTESA-N 427092 US10544132, Example 47::US10981898, Example 47::US11236047, Example 47 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 430 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427092&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281412 434321408 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025420 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 7.30 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025421 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCCO)c1ccc(Cl)cc1 InChI=1S/C27H27Cl2NO4/c1-26(2,33)20-8-13-24-23(16-20)25(32)30(17-18-4-9-21(28)10-5-18)27(24,34-15-3-14-31)19-6-11-22(29)12-7-19/h4-13,16,31,33H,3,14-15,17H2,1-2H3/t27-/m1/s1 OAZOTQYKBROZDC-HHHXNRCGSA-N 427095 US10544132, Example 49::US10981898, Example 49::US11236047, Example 49 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 82.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427095&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281478 434321410 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025422 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO6S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,40-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)41(3,38)39/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 UZPANWLGEIIIFW-SSEXGKCCSA-N 427098 US10544132, Example 50::US10981898, Example 62::US11236047, Example 50 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.800 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427098&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281647 434321413 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025423 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC(F)(F)CO)c1ccc(Cl)cc1 InChI=1S/C27H25Cl2F2NO4/c1-25(2,35)19-7-12-23-22(13-19)24(34)32(14-17-3-8-20(28)9-4-17)27(23,36-16-26(30,31)15-33)18-5-10-21(29)11-6-18/h3-13,33,35H,14-16H2,1-2H3/t27-/m1/s1 DKLIPENWHNVPEY-HHHXNRCGSA-N 427099 US10544132, Example 51::US10981898, Example 51::US11236047, Example 51 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 130 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427099&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281507 434321414 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025424 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CC[C@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21+,30+/m0/s1 YJPCYIKTKXDGAX-KSWJDTNCSA-N 427101 US10544132, Example 52::US10981898, Example 52::US11236047, Example 53 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 150 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427101&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 137411534 434321416 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025425 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@@H]1CC[C@@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21+,30-/m1/s1 YJPCYIKTKXDGAX-PHKGMDLESA-N 492956 US10981898, Example 53 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 120 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492956&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 137411532 447119645 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025426 C[C@](O)(C(=O)N1CCCC1)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2N2O5/c1-31(41,30(40)36-16-2-3-17-36)24-8-13-28-27(18-24)29(39)37(19-22-4-9-25(34)10-5-22)33(28,23-6-11-26(35)12-7-23)42-21-32(20-38)14-15-32/h4-13,18,38,41H,2-3,14-17,19-21H2,1H3/t31-,33-/m1/s1 AVCINXLMIYQZIG-ZQWAWDFXSA-N 492957 2-((R)-1-((1-(((tert-Butyldimethylsilyl)oxy)methyl)cyclopropyl)methoxy)-2-(4-chlorobenzyl)-1-(4-chlorophenyl)-3-oxoisoindolin-5-yl)-2-hydroxypropanoic acid::US10981898, Example 54 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 150 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492957&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 156907819 447119646 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025427 CN(C)C(=O)[C@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2N2O5/c1-29(39,28(38)34(2)3)22-8-13-26-25(16-22)27(37)35(17-20-4-9-23(32)10-5-20)31(26,21-6-11-24(33)12-7-21)40-19-30(18-36)14-15-30/h4-13,16,36,39H,14-15,17-19H2,1-3H3/t29-,31-/m1/s1 QSQWTXWPCPYZCQ-BVRKHOPBSA-N 427108 US10544132, Example 57::US10981898, Example 56 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 120 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427108&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732970 434321422 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025428 CN(C)C(=O)[C@@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2N2O5/c1-29(39,28(38)34(2)3)22-8-13-26-25(16-22)27(37)35(17-20-4-9-23(32)10-5-20)31(26,21-6-11-24(33)12-7-21)40-19-30(18-36)14-15-30/h4-13,16,36,39H,14-15,17-19H2,1-3H3/t29-,31+/m0/s1 QSQWTXWPCPYZCQ-IGYGKHONSA-N 427104 US10544132, Example 56::US10981898, Example 57 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 61.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427104&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732969 434321419 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025429 CNC(=O)[C@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28-,30-/m1/s1 FLAAYSHQWIAMDD-PQHLKRTFSA-N 427110 2-[(1R)-1-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-5-yl]-2-hydroxy-N-methylpropanamide::US10544132, Example 59::US10981898, Example 58 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 18.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427110&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732972 434321424 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025430 CNC(=O)[C@@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28-,30+/m0/s1 FLAAYSHQWIAMDD-MFMCTBQISA-N 427109 2-[(1R)-1-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-5-yl]-2-hydroxy-N-methylpropanamide::US10544132, Example 58::US10981898, Example 59 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 4.10 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427109&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732971 434321423 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025431 CSc1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO4S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,38-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)39-3/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 OAWFYJRYUZCBKK-SSEXGKCCSA-N 427111 US10544132, Example 60::US10981898, Example 60::US11236047, Example 60 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 14.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427111&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281694 434321425 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025432 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO6S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,40-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)41(3,38)39/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 UZPANWLGEIIIFW-SSEXGKCCSA-N 427098 US10544132, Example 50::US10981898, Example 62::US11236047, Example 50 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 16.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427098&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281647 434321413 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025433 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO6S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,40-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)41(3,38)39/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 UZPANWLGEIIIFW-SSEXGKCCSA-N 427098 US10544132, Example 50::US10981898, Example 62::US11236047, Example 50 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 2.30 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427098&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281647 434321413 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025434 COC[C@@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FNO7S/c1-29(38,17-41-2)21-12-24-27(25(34)13-21)31(20-5-8-22(32)9-6-20,42-18-30(16-36)10-11-30)35(28(24)37)15-19-4-7-23(33)14-26(19)43(3,39)40/h4-9,12-14,36,38H,10-11,15-18H2,1-3H3/t29-,31-/m1/s1 XPPOSVDBYKUPEU-BVRKHOPBSA-N 427116 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-(2-hydroxy-1-methoxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 63::US10981898, Example 64 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 2.10 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427116&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732975 434321430 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025435 C[C@@](O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28-,30-/m1/s1 HJVLHGXGDKFDKJ-PQHLKRTFSA-N 427118 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-6-(1,2-dihydroxypropan-2-yl)-4-fluoro-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 65::US10981898, Example 65 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.80 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427118&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732977 434321432 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025436 C[C@](O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28-,30+/m0/s1 HJVLHGXGDKFDKJ-MFMCTBQISA-N 427119 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-6-(1,2-dihydroxypropan-2-yl)-4-fluoro-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 66::US10981898, Example 66 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 3.00 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427119&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732978 434321433 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025437 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33?,34-/m1/s1 GEZPZMXREXHEJZ-GKHSUDMDSA-N 492968 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(4-methylpiperazin-1-yl)propan-2-yl]-3-[(3R)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-1-one (*both isomers at the position shown)::US10981898, Example 68 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 7.00 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492968&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281696 447119657 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025438 CN1CCN(C[C@@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33+,34+/m0/s1 GEZPZMXREXHEJZ-HOMOBGQPSA-N 427123 US10544132, Example 70::US10981898, Example 69 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.700 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427123&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732982 434321437 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025439 CN1CCN(C[C@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33-,34+/m0/s1 GEZPZMXREXHEJZ-FBBJSWSOSA-N 427122 US10544132, Example 69::US10981898, Example 70 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 5.70 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427122&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732981 434321436 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025440 CC(C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FNO6/c1-29(2,38)19-13-23-27(24(33)14-19)30(40-22-11-12-39-16-22,18-5-9-21(32)10-6-18)34(28(23)37)25(15-26(35)36)17-3-7-20(31)8-4-17/h3-10,13-14,22,25,38H,11-12,15-16H2,1-2H3,(H,35,36)/t22-,25-,30+/m0/s1 PMXGSEVMEXTCLI-SGOMLOLCSA-N 427124 US10544132, Example 71::US10981898, Example 71::US11236047, Example 71 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 2.00 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427124&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281459 434321438 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025441 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3CO)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN2O4/c1-28(2,38)21-12-24-26(25(33)13-21)30(20-4-7-22(31)8-5-20,39-17-29(16-34)9-10-29)35(27(24)37)14-18-3-6-23(32)11-19(18)15-36/h3-8,11-13,36,38H,9-10,14-15,17H2,1-2H3/t30-/m1/s1 FZOWPLQXTSEWMX-SSEXGKCCSA-N 427125 US10544132, Example 72::US10981898, Example 72::US11236047, Example 72 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.50 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427125&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281421 434321439 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025442 Cn1cc(cn1)[C@@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31-,33+/m0/s1 YLXVSCUQMYZKFT-CQTOTRCISA-N 427126 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-pyrazol-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 73::US10981898, Example 73 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 12.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427126&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732983 434321440 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025443 Cn1cc(cn1)[C@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31-,33-/m1/s1 YLXVSCUQMYZKFT-ZQWAWDFXSA-N 427127 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-pyrazol-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 74::US10981898, Example 74 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.500 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427127&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732984 434321441 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025444 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O6S/c1-30(40,22-15-36-37(2)17-22)21-12-25-28(26(35)13-21)32(44-18-31(41)10-11-31,20-5-8-23(33)9-6-20)38(29(25)39)16-19-4-7-24(34)14-27(19)45(3,42)43/h4-9,12-15,17,40-41H,10-11,16,18H2,1-3H3/t30?,32-/m1/s1 FATKFLNSLQQUOY-BDJZEIKTSA-N 492975 US10981898, Example 76::US11236047, Example 76 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 9.50 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492975&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281442 447119664 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025445 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OCC4(CO)CC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H40Cl2FN3O6S/c1-33(44,20-40-14-12-39(2)13-15-40)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,47-22-34(21-42)10-11-34)41(32(28)43)19-23-4-7-27(37)18-30(23)48(3,45)46/h4-9,16-18,42,44H,10-15,19-22H2,1-3H3/t33?,35-/m1/s1 UAASDXMLTUDYGD-PWXSHKNQSA-N 492976 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(4-methylpiperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10981898, Example 78::US11236047, Example 78 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 4.60 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492976&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281423 447119665 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025446 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3Br)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H24BrCl2FN2O3/c1-27(2,37)19-11-22-25(24(33)12-19)29(18-4-7-20(31)8-5-18,38-16-28(15-34)9-10-28)35(26(22)36)14-17-3-6-21(32)13-23(17)30/h3-8,11-13,37H,9-10,14,16H2,1-2H3/t29-/m1/s1 HONPZSDBHRBCAL-GDLZYMKVSA-N 492977 US10981898, Example 79 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 2.20 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492977&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281574 447119666 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025447 CN1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)C(O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2FN2O5S/c1-29(37,19-10-12-34(2)13-11-19)21-14-24-27(25(33)15-21)30(38,20-5-8-22(31)9-6-20)35(28(24)36)17-18-4-7-23(32)16-26(18)41(3,39)40/h4-9,14-16,19,37-38H,10-13,17H2,1-3H3 NNVXEGMVOBLWBC-UHFFFAOYSA-N 492978 US10981898, Example 81 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 2.60 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492978&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281432 447119667 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025448 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3P(C)(C)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2FNO5P/c1-29(2,38)21-13-24-27(25(34)14-21)31(20-6-9-22(32)10-7-20,40-18-30(17-36)11-12-30)35(28(24)37)16-19-5-8-23(33)15-26(19)41(3,4)39/h5-10,13-15,36,38H,11-12,16-18H2,1-4H3/t31-/m1/s1 IARKWVZHJYWTDX-WJOKGBTCSA-N 427135 US10544132, Example 82::US10981898, Example 82::US11236047, Example 82 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 2.50 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427135&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 137405337 434321449 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025449 CS(=O)(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)[C@H](O)C1CCOCC1 InChI=1S/C33H34Cl2FNO7S/c1-45(41,42)28-16-25(35)5-2-21(28)17-37-31(40)26-14-22(30(39)20-8-12-43-13-9-20)15-27(36)29(26)33(37,23-3-6-24(34)7-4-23)44-19-32(18-38)10-11-32/h2-7,14-16,20,30,38-39H,8-13,17-19H2,1H3/t30-,33-/m1/s1 IRIZYNABKNVLML-LXANVCGNSA-N 427139 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[hydroxy(oxan-4-yl)methyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 84::US10981898, Example 83 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.000 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427139&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732991 434321453 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025450 C[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN2O7S/c1-32(42,21-9-13-45-14-10-21)23-15-26-29(27(37)16-23)34(22-4-7-24(35)8-5-22,46-19-33(11-12-33)31(38)41)39(30(26)40)18-20-3-6-25(36)17-28(20)47(2,43)44/h3-8,15-17,21,42H,9-14,18-19H2,1-2H3,(H2,38,41)/t32-,34-/m1/s1 WPEIHYLRRFWOGP-ZFEZZJPFSA-N 427143 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 85::US10981898, Example 85 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.490 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427143&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732993 434321457 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025451 C[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN2O7S/c1-32(42,21-9-13-45-14-10-21)23-15-26-29(27(37)16-23)34(22-4-7-24(35)8-5-22,46-19-33(11-12-33)31(38)41)39(30(26)40)18-20-3-6-25(36)17-28(20)47(2,43)44/h3-8,15-17,21,42H,9-14,18-19H2,1-2H3,(H2,38,41)/t32-,34+/m0/s1 WPEIHYLRRFWOGP-UZNNEEJFSA-N 427145 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 86::US10981898, Example 86 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 56000 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427145&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732994 434321459 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025452 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@@](C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30-,31+/m0/s1 AVDHVIXZENQIRS-HOSFBAFGSA-N 427147 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 88::US10981898, Example 88 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.790 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427147&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732995 434321461 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025453 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@](C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30+,31+/m0/s1 AVDHVIXZENQIRS-MAJWKWKESA-N 427148 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 89::US10981898, Example 89 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 12.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427148&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154732996 434321462 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025454 CC[C@@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-3-32(41,29-18-38(2)20-37-29)24-14-27-30(28(35)15-24)33(43-26-12-13-42-19-26,23-8-10-25(34)11-9-23)39(31(27)40)17-22-6-4-21(16-36)5-7-22/h4-11,14-15,18,20,26,41H,3,12-13,17,19H2,1-2H3/t26-,32-,33+/m0/s1 CDUKUNZREUVQKN-FRJUPVQCSA-N 427156 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[I-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 96::US10981898, Example 96 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.640 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427156&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154733003 434321470 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025455 CC[C@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-3-32(41,29-18-38(2)20-37-29)24-14-27-30(28(35)15-24)33(43-26-12-13-42-19-26,23-8-10-25(34)11-9-23)39(31(27)40)17-22-6-4-21(16-36)5-7-22/h4-11,14-15,18,20,26,41H,3,12-13,17,19H2,1-2H3/t26-,32+,33+/m0/s1 CDUKUNZREUVQKN-WNNZTAQKSA-N 427157 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[I-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 97::US10981898, Example 97 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 45000 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427157&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154733004 434321471 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025456 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@](C)(O)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-29(40,30(35)11-13-42-14-12-30)20-15-23-27(24(34)16-20)31(41-2,19-5-9-22(33)10-6-19)36(28(23)39)25(17-26(37)38)18-3-7-21(32)8-4-18/h3-10,15-16,25,40H,11-14,17H2,1-2H3,(H,37,38)/t25-,29-,31+/m0/s1 HZTQINJSGAPBLS-ZITMISKDSA-N 492987 US10981898, Example 98 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.800 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492987&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 156907832 447119676 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025457 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@@](C)(O)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-29(40,30(35)11-13-42-14-12-30)20-15-23-27(24(34)16-20)31(41-2,19-5-9-22(33)10-6-19)36(28(23)39)25(17-26(37)38)18-3-7-21(32)8-4-18/h3-10,15-16,25,40H,11-14,17H2,1-2H3,(H,37,38)/t25-,29+,31+/m0/s1 HZTQINJSGAPBLS-FPHQXIGGSA-N 492988 US10981898, Example 99 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 12.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492988&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 156907833 447119677 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025458 CCC(O)(c1ccn(C)n1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O5/c1-4-31(42,27-15-16-37(2)36-27)21-17-24-29(25(35)18-21)32(43-3,20-7-11-23(34)12-8-20)38(30(24)41)26(13-14-28(39)40)19-5-9-22(33)10-6-19/h5-12,15-18,26,42H,4,13-14H2,1-3H3,(H,39,40)/t26-,31?,32+/m0/s1 ACCSRYKZIIOHIZ-LTZUXFEUSA-N 427160 US10544132, Example 100::US10981898, Example 100::US11236047, Example 100 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 6.30 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427160&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281496 434321474 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025459 CC[C@](O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H31Cl2F2NO6/c1-3-31(41,30(36)12-14-43-15-13-30)21-16-24-28(25(35)17-21)32(42-2,20-6-10-23(34)11-7-20)37(29(24)40)26(18-27(38)39)19-4-8-22(33)9-5-19/h4-11,16-17,26,41H,3,12-15,18H2,1-2H3,(H,38,39)/t26-,31-,32+/m0/s1 HXHSKGLWTNIZIS-XBZWSRNISA-N 427161 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-(4-fluorooxan-4-yl)-1-hydroxypropyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 101::US10981898, Example 102 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 17.0 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427161&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154733007 434321475 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025460 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-3-32(41,21-14-16-43-17-15-21)23-18-26-30(27(36)19-23)33(42-2,22-6-10-25(35)11-7-22)37(31(26)40)28(12-13-29(38)39)20-4-8-24(34)9-5-20/h4-11,18-19,21,28,41H,3,12-17H2,1-2H3,(H,38,39)/t28-,32+,33+/m0/s1 YDGNPXHTWKENIC-XEUSQTKLSA-N 427168 US10544132, Example 108::US10981898, Example 108::US11236047, Example 108 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 6.10 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427168&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281545 434321482 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025461 CC[C@](C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-3-29(2,40)20-12-23-27(24(34)13-20)31(19-6-10-22(33)11-7-19,42-17-30(35)15-41-16-30)36(28(23)39)25(14-26(37)38)18-4-8-21(32)9-5-18/h4-13,25,40H,3,14-17H2,1-2H3,(H,37,38)/t25-,29-,31+/m0/s1 NAMQEWAUDBCILZ-ZITMISKDSA-N 427184 US10544132, Example 125::US10981898, Example 126 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.90 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427184&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154733014 434321497 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025462 CC[C@](O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)c1ccccn1 InChI=1S/C32H27Cl2FN2O5/c1-3-31(41,27-6-4-5-15-36-27)21-16-24-29(25(35)17-21)32(42-2,20-9-13-23(34)14-10-20)37(30(24)40)26(18-28(38)39)19-7-11-22(33)12-8-19/h4-17,26,41H,3,18H2,1-2H3,(H,38,39)/t26-,31-,32+/m0/s1 KHSRSNYUTBONQS-XBZWSRNISA-N 427187 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(pyridin-2-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 128::US10981898, Example 127 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 4.50 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427187&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 154733017 434321500 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025463 CC[C@](O)(C1CCN(CC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H33Cl2FN2O5/c1-3-31(41,21-12-14-36(15-13-21)19-28(38)39)23-16-26-29(27(35)17-23)32(42-2,22-6-10-25(34)11-7-22)37(30(26)40)18-20-4-8-24(33)9-5-20/h4-11,16-17,21,41H,3,12-15,18-19H2,1-2H3,(H,38,39)/t31-,32+/m0/s1 MFPOPVHVIGVWNK-AJQTZOPKSA-N 427194 US10544132, Example 135::US10981898, Example 134::US11236047, Example 134 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.10 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427194&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281570 434321507 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025464 CC[C@](O)(C1CCN(CCC(=O)OC)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H37Cl2FN2O5/c1-4-33(42,23-13-16-38(17-14-23)18-15-30(40)43-2)25-19-28-31(29(37)20-25)34(44-3,24-7-11-27(36)12-8-24)39(32(28)41)21-22-5-9-26(35)10-6-22/h5-12,19-20,23,42H,4,13-18,21H2,1-3H3/t33-,34+/m0/s1 ATEBGPCVCPBSLM-SZAHLOSFSA-N 427195 US10544132, Example 136::US10981898, Example 137::US11236047, Example 136 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 1.30 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427195&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281761 434321508 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 1025465 CC[C@](O)(C1CCN(CCC(=O)OC)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H37Cl2FN2O5/c1-4-33(42,23-13-16-38(17-14-23)18-15-30(40)43-2)25-19-28-31(29(37)20-25)34(44-3,24-7-11-27(36)12-8-24)39(32(28)41)21-22-5-9-26(35)10-6-22/h5-12,19-20,23,42H,4,13-18,21H2,1-3H3/t33-,34+/m0/s1 ATEBGPCVCPBSLM-SZAHLOSFSA-N 427195 US10544132, Example 136::US10981898, Example 137::US11236047, Example 136 Cellular tumor antigen p53 [1-83]/E3 ubiquitin-protein ligase Mdm2 [1-188] Human 0.570 US Patent 10.7270/Q2154M5V aid1805473 US10981898 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 4/20/2021 10/26/2021 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50003613&target=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427195&enzyme=Cellular+tumor+antigen+p53+%5B1-83%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B1-188%5D&column=ki&startPg=0&Increment=50&submit=Search 135281761 434321508 2 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPA 2GS0,2L14,2LY4,5HOU,5HPD,6XRE,7XZZ,8F2H,8F2I Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61